1 Cardiovascular Research Institute and the Department of Anesthesia, University of California, San Francisco Medical Center, San Francisco, California 94122; Department of Anesthcsiology, 1081 Scaife Hall, University of Pittsburgh, Pittsburgh, Pennsylvania 15213
Entry into CSF and consumption by brain of blood-borne lactate (La) was quantified in pentobarbital-anesthetized, normocapnic dogs loaded and infused with NaLa and HLa to hold constant, in arterial blood, both the La concentration at about 8 mM (normal = 1 mM) and the pH at 7.4. In four dogs studied hourly over six hours, the arteriosagittal sinus blood concentration difference (
© 1974 American Heart Association, Inc.
Lactate Uptake and Metabolism by Brain During Hyperlactatemia and Hypoglycemia
2 Cardiovascular Research Institute and the Department of Anesthesia, University of California, San Francisco Medical Center, San Francisco, California 94122
A-V La) was 0.41 ± 0.14 (SE) mM (P <0.05) and was time independent. CSF La rose slowly over four hours to about 0.6 of blood La while cisternal CSF pH remained nearly constant. Four acetate loaded controls showed no changes of
A-V La, CSF La, CSF, or arterial pH. Brain uptake of La was quantitated in eight dogs during insulin-induced hypoglycemia, to minimize possible competition by glucose. Cerebral blood flow (CBF) and
A-V for La, glucose, and O2 were determined at 30-minute intervals. CBF and cerebral metabolic rate of O2 (CMRO2) both fell about 17% during two hours of hypoglycemia and returned to control with La loading although blood glucose continued to fall to 1.5 mM. In the two hour La loaded period
A-V La was 0.27 ± 0.10 mM (n = 32) and CSF La rose to 0.7 of arterial La without altering CSF pH. CMRO2 averaged 1.61 ± 0.14 µ mol/(min.gm brain), of which CMR glucose (x6 to give O2, equivalents) provided 75% or 1.18 ± 0.13 µ O2 eq/(min.gm). CMR La x 3 was 28% of CMRO2 or 0.45 ± 0.15 µ eq/(min.gm). The results suggest that blood-borne La can stoichiometrically replace about one-fourth of the glucose used as brain substrate during hypoglycemia, and probably during normoglycemia. Uptake may be limited by saturation of carriers facilitating passage of La across the blood-brain barrier and into brain cells.
Key Words: cerebrospinal fluid glucose cerebral blood flow lactacidemia blood-brain barrier
This article has been cited by other articles:
![]() |
J. M. Lubow, I. G. Pinon, A. Avogaro, C. Cobelli, D. M. Treeson, K. A. Mandeville, G. Toffolo, and P. J. Boyle Brain oxygen utilization is unchanged by hypoglycemia in normal humans: lactate, alanine, and leucine uptake are not sufficient to offset energy deficit Am J Physiol Endocrinol Metab, January 1, 2006; 290(1): E149 - E153. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. M. Koehler-Stec, I. A. Simpson, S. J. Vannucci, K. T. Landschulz, and W. H. Landschulz Monocarboxylate transporter expression in mouse brain Am J Physiol Endocrinol Metab, September 1, 1998; 275(3): E516 - E524. [Abstract] [Full Text] [PDF] |
||||
|
Stroke Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 1974 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |